Ophthalmology · San Antonio, TX
NPI
1508889403
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
303 E Quincy St, Suite 100
San Antonio, TX, 78215
Phone (210) 271-7648
Groups this clinician bills Medicare through
Medicare paid, 2024
$397K
3,388 services
Medicare patients, 2024
338
Average age 75
Drug cost, 2024
$1.9M
873 prescriptions
Company payments, 2025
$1,149
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Felipe A Navas was code 92134 (computerized ophthalmic imaging), 521 times for 296 patients. In total Felipe A Navas billed 3,388 services in 29 codes, and Medicare paid $397K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 521 | 296 | $30.68 | $16K |
| 92014 Ophthalmological E&M | Office | 501 | 281 | $91.43 | $46K |
| J0178 Injection, aflibercept, 1 mg | Office | 302 | 40 | $654.82 | $198K |
| 67028 Intravitreal Injection | Office | 296 | 66 | $86.44 | $26K |
| J7999 Compounded drug, not otherwise classified | Office | 96 | 34 | $65.55 | $6,292 |
| 99204 Office E&M - New | Office | 87 | 87 | $127.04 | $11K |
| 92201 Ophthalmological E&M | Office | 86 | 86 | $18.82 | $1,618 |
| 92250 Angiography | Office | 65 | 62 | $26.99 | $1,754 |
| 92235 Angiography | Office | 60 | 58 | $127.21 | $7,633 |
By year: 2022 $307K for 2,013 services; 2023 $303K for 2,428 services; 2024 $397K for 3,388 services.
Medicare prescription drug claims, 2024
In 2024, the drug Felipe A Navas prescribed most often to Medicare patients was Eylea (Aflibercept), with 566 prescriptions and refills. In total Felipe A Navas wrote 873 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 566 | 570 | 141 | $1.5M |
| Vabysmo Faricimab-Svoa | 78 | 82 | 23 | $255K |
| Prednisolone Acetate Generic | 41 | 42 | 13 | $1,264 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 30 | 80 | 18 | $256 |
| Eylea Hd Aflibercept | 23 | 30 | Under 11 | $85K |
| Ketorolac Tromethamine Generic | 21 | 21 | Under 11 | $479 |
| Ilevro Nepafenac | 21 | 30 | 11 | $7,879 |
| Izervay Avacincaptad Pegol Sodium/Pf | 18 | 18 | Under 11 | $56K |
| Bromfenac Sodium Generic | 16 | 18 | Under 11 | $1,830 |
| Brimonidine Tartrate Generic | 12 | 13 | Under 11 | $95.1 |
Brand drugs: 772 claims; generic drugs: 101 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Felipe A Navas $1,149 ($1,149 in general payments such as food, travel and fees) from 7 companies. The largest payer was Astellas Pharma US Inc with $270.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.